Our investment
In December 2016, CDC committed $25 million to the Phi Capital Fund, alongside investments from German DFI DEG. The fund reached a total size of $60 million and is looking for investments between $5 million to $15 million. Our investment aims to unlock the growth potential of medium-sized businesses. It also helps attract other investors to the fund.
Expected impact
Many Indian businesses are family owned, and often grapple with the challenges of globalisation, increased competition and building a professional organisation. Businesses that are unable to successfully meet these challenges typically fail.
Our investment enables the fund manager to target family businesses and operationally challenged companies to give them access to working capital.
The fund manager also provides strategic and operational support to increase productivity to help transform investee companies into sustainable world-class businesses.
It has already made an investment in Arya Vaidya Pharmacy, a Tamil Nadu-based ayurvedic healthcare firm.
Environmental and social aspects
We are working closely with the fund manager to develop and implement an Environmental and Social Management System (ESMS).
Key facts
- Status:
- Active
- Region
:
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- South Asia
- Sector
:
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people. For funds, the sectors listed here are those the fund has invested in so far.
- Health, Manufacturing
- Website:
- https://protect-eu.mimecast.com/s/X-8ZC7LJniADzAPH8gE-4t?domain=phicapital.in
- Investment type
:
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund manager:
- Phi Capital
- Start date
:
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- November 2016
- Amount
:
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
- $25m
- Domicile
:
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
- Mauritius
Investments made by this fund
- Active
- Exited
| Investment name | Country | Region | Sector | Start date | Status |
|---|---|---|---|---|---|
|
The Arya Vaidya Pharmacy (Coimbatore) Limited
The Arya Vaidya Pharmacy (Coimbatore) Limited (“AVP†or “Companyâ€) is a renowned healthcare and wellness company in South India focusing on herbal and natural remedies based on Ayurveda: a traditional system of medicine prevalent in the Indian subcontinent since ancient times. |
India | South Asia | Health | June 2017 | Active |
| Classic Legends Private Limited | India | South Asia | Manufacturing | October 2017 | Active |
|
Krsnaa Diagnostics Private Limited
Krsnaa Diagnostics is India's largest diagnostic services provider, both in Radiology and Pathology. Healthcare Diagnostics at affordable rates. |
India | South Asia | Health | January 2019 | Active |
